Semler’s Unique 50%+ EBITDA Margin Is A Thing To Marvel At
The pandemic blip seems all but a distant memory for the company even if not all of the risk has cleared. The company just keeps growing and producing awe-inspiring margins, […]
Semler’s Growth Is Resuming
While the company has experienced headwinds from the pandemic, growth is already returning. The company has a solid growth trajectory generating 90% gross margins and increasing amounts of free cash […]
Semler Scientific: A Little Gem Of A Company
The company has simplified the testing of PAD, which is a marker for increased risk of stroke and cardiovascular disease. It runs on a capital light, license fee business model […]